CRSP vs VRTX · rev $11.6M vs P/E 30, rev $3.33B
Crispr Therapeutics AG (CRSP) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CRSP currently screens at market cap $5.42B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CRSP and VRTX stock pages for the full models.
Not investment advice.